TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)
Launched by GLAXOSMITHKLINE · Oct 12, 2006
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least a 6 month history of probably migraine (6 migraine attacks per month)
- • Males and women of childbearing potential on a adequate contraception.
- Exclusion Criteria:
- • Physician diagnosis of migraine; history of triptan or ergot use; history of headache prophylaxis use
- • Pregnant and/or nursing mother
- • History of cardiovascular disease.
- • Uncontrolled hypertension.
- • Basilar or Hemiplegic migraine
- • History of stroke or transient ischemic attacks (TIA).
- • History of epilepsy or treated with anti-epileptics within the past 5 years.
- • Impaired hepatic or renal function.
- • History of gastrointestinal bleeding or ulceration.
- • Allergy or hypersensitivity to Aspirin or any other NSAID.
- • Allergy or hypersensitivity to triptans.
- • Participated in an investigational drug trial in the previous 4 weeks.
About Glaxosmithkline
GlaxoSmithKline (GSK) is a global healthcare company dedicated to improving the quality of human life by enabling people to do more, feel better, and live longer. With a strong focus on research and development, GSK specializes in pharmaceuticals, vaccines, and consumer health products. The company is committed to advancing innovative therapies and preventive measures across various therapeutic areas, including respiratory, oncology, immunology, and infectious diseases. GSK's collaborative approach and rigorous clinical trial processes underscore its dedication to delivering safe and effective healthcare solutions that meet the needs of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Seattle, Washington, United States
Chicago, Illinois, United States
Little Rock, Arkansas, United States
New Orleans, Louisiana, United States
Raleigh, North Carolina, United States
San Antonio, Texas, United States
Chapel Hill, North Carolina, United States
Houston, Texas, United States
West Palm Beach, Florida, United States
Cleveland, Ohio, United States
Medford, Oregon, United States
Nashville, Tennessee, United States
Pittsburgh, Pennsylvania, United States
Bellaire, Texas, United States
Salt Lake City, Utah, United States
Phoenix, Arizona, United States
Anaheim, California, United States
Newport Beach, California, United States
San Diego, California, United States
Santa Monica, California, United States
St. Louis, Missouri, United States
Rochester, New York, United States
Simpsonville, South Carolina, United States
Albuquerque, New Mexico, United States
Wichita, Kansas, United States
Austin, Texas, United States
Kalamazoo, Michigan, United States
Pembroke Pines, Florida, United States
Colorado Springs, Colorado, United States
Greensboro, North Carolina, United States
Anderson, South Carolina, United States
Wenatchee, Washington, United States
Milwaukee, Wisconsin, United States
Springfield, Missouri, United States
Stamford, Connecticut, United States
New York, New York, United States
North Dartmouth, Massachusetts, United States
West Jordan, Utah, United States
Carnegie, Pennsylvania, United States
Walnut Creek, California, United States
Westerville, Ohio, United States
Alexandria, Virginia, United States
Katy, Texas, United States
Evansville, Indiana, United States
Ann Arbor, Michigan, United States
St. Louis Park, Minnesota, United States
Albany, New York, United States
Valley Stream, New York, United States
West Chester, Ohio, United States
San Francisco, California, United States
Westlake Village, California, United States
Las Vegas, Nevada, United States
Philadelphia, Pennsylvania, United States
Buena Park, California, United States
Richardson, Texas, United States
Atlanta, Georgia, United States
Cincinnati, Ohio, United States
Independence, Ohio, United States
Diamond Bar, California, United States
Miami, Florida, United States
Patients applied
Trial Officials
GSK Clinical Trials
Study Director
GlaxoSmithKline
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials